Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
07/2012
07/11/2012CN101282978B Macrocylic inhibitors of hepatitis c virus
07/11/2012CN101077866B Substituted benzoxazoles antifungal compounds and preparation method thereof
07/10/2012US8217171 Antiviral agents
07/10/2012US8217138 Anti-inflammatory compounds and uses thereof
07/10/2012US8217077 HMB uses thereof
07/10/2012US8217019 AIDS virus vaccines using Sendai virus vector
07/10/2012US8216805 Knobs and holes heteromeric polypeptides
07/10/2012US8216599 Administering hydroxytyrosol and oleuropein in a ratio of 1:1-200:1
07/10/2012US8216587 Method of vaccination
07/10/2012US8216569 Vascular endothelial growth factor 2
07/10/2012CA2518437C Non-nucleoside reverse transcriptase inhibitors i for treating hiv mediated diseases
07/10/2012CA2513463C Gyrase inhibitors and uses thereof
07/10/2012CA2511505C Biguanide and dihydrotriazine derivatives
07/10/2012CA2501812C Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages
07/10/2012CA2485253C Lipid a and other carbohydrate ligand analogs
07/10/2012CA2481369C Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease
07/10/2012CA2477954C Means and methods for the production of adenovirus vectors
07/10/2012CA2462930C Remodeling and glycoconjugation of peptides
07/10/2012CA2446951C Polythiourea lipid derivatives
07/10/2012CA2446356C Use of compositions for treating rosacea
07/10/2012CA2444704C Synthesis and evaluation of phthalimide mimics as anti-angiogenic agents
07/10/2012CA2429543C Method for obtaining antigenic aggregates and the use thereof in formulations
07/10/2012CA2417960C Method of using diketopiperazines and composition containing them
07/10/2012CA2417311C Crystalline alkali metal salts of lansoprazole and their production and use
07/10/2012CA2382336C Vaccines from infectious agents
07/10/2012CA2372583C Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines
07/10/2012CA2319327C Sterile complex of therapeutic peptide bond to a polysaccharide
07/06/2012CA2775393A1 Topical non-aqueous pharmaceutical formulations
07/05/2012WO2012092484A2 Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections
07/05/2012WO2012092411A2 Phenanthridine macrocyclic hepatitis c serine protease inhibitors
07/05/2012WO2012092409A2 Macrocyclic hepatitis c serine protease inhibitors
07/05/2012WO2012092226A1 Veterinary vaccine composition against infections caused by salmonella
07/05/2012WO2012092157A2 Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
07/05/2012WO2012092153A1 Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
07/05/2012WO2012092053A1 Bovine viral diarrhea virus type 1b vaccine compositions and methods
07/05/2012WO2012091610A1 Drug with activity against the herpes virus family
07/05/2012WO2012091589A1 The use of viburnum opulus or its tissues or products thereof for the prevention or treatment of herpes virus infections
07/05/2012WO2012091534A1 Antibacterial agent for treating infectious diseases of bacterial origin
07/05/2012WO2012091081A1 Interferon production-inducing agent containing lactic acid bacteria
07/05/2012WO2012090895A1 Monoclonal antibody capable of recognizing human papilloma virus (hpv) l2 protein, and method for measuring hpv-neutralizing antibody titer using same
07/05/2012WO2012090218A1 Synergistic effects of the combination of the specific compounds with paracetamol and their effects on various diseases
07/05/2012WO2012090136A1 Novel antibacterial compounds
07/05/2012WO2012090124A2 IN SITU GENERATION OF PEROXYCARBOXYLIC ACIDS AT ALKALINE pH, AND METHODS OF USE THEREOF
07/05/2012WO2012090000A1 Inactivated poliovaccine
07/05/2012WO2012089833A2 Expression Systems
07/05/2012WO2012089808A1 New allium porrum l. extract with powerful cicatrizant, anti-inflammatory and anti-microbic activity, for cutaneous lesion treating and its preparation method
07/05/2012WO2012089338A1 Combination of vaccination and inhibition of mhc class restricted antigen presentation
07/05/2012WO2012089231A1 Paramyxovirus vaccines
07/05/2012WO2012089225A1 Combination of vaccination and inhibition of mhc class i restricted antigen presentation
07/05/2012WO2012089220A1 Method for producing a water-soluble medicinal form of an antibiotic from the group consisting of rifamycins, and composition produced by said method
07/05/2012WO2012089175A2 Traditional chinese medicinal tea made by microbial fermentation
07/05/2012WO2012089058A1 Crystalline form of ertapenem sodium and preparation method therefor
07/05/2012WO2012088763A1 Hepatitis a virus strain sh and method for adapting same to diploid cells
07/05/2012WO2012088739A1 Method for preparing fusion protein of mycobacterium tuberculosis antigens and uses thereof
07/05/2012WO2012053827A9 Composition containing peptide ligand bonding with cxcr2 for treating infective and inflammatory diseases
07/05/2012WO2012045083A9 Minimizing intestinal dysfunction
07/05/2012WO2012037498A3 Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo
07/05/2012WO2012030513A3 Methods of treating bacterial infections through pulmonary delivery of fusidic acid
07/05/2012WO2012026988A3 Dendrimeric peptides, pharmaceutical compositions and methods of using the same
07/05/2012WO2012021730A3 Respiratory syncytial virus (rsv) vaccine
07/05/2012WO2012018813A3 Modified infectious laryngotracheitis virus (iltv) and uses thereof
07/05/2012US20120172591 Inhibitors of human phosphatidylinositol 3-kinase delta
07/05/2012US20120172423 Compositions and methods for treating herpes simplex virus
07/05/2012US20120172408 Active ingredient comprising indocyanine green and/or infracyanine green
07/05/2012US20120172402 Induction of alpha helix conformations in proteins and peptides
07/05/2012US20120172397 HEXAHYDROCYCLOPENTA[f]INDAZOLE 5-YL ETHANOLS AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
07/05/2012US20120172396 2-adamantylurea derivatives as selective 11b-hsd1 inhibitors
07/05/2012US20120172368 Bis-Benzimidazole Derivatives
07/05/2012US20120172367 Macrocyclic integrase inhibitors
07/05/2012US20120172364 Rate-controlled particles
07/05/2012US20120172342 Biotherapeutics For the Treatment of Infectious Diseases
07/05/2012US20120172336 Fosfluconazole Derivatives, Synthesis, and Use in Long Acting Formulations
07/05/2012US20120172333 Pyrrolo-pyridine derivatives as activators of ampk
07/05/2012US20120172332 Antibacterial aminoglycoside analogs
07/05/2012US20120172331 Methods of using human milk oligosaccharides for improving airway respiratory health
07/05/2012US20120172330 Human milk oligosaccharides for modulating inflammation
07/05/2012US20120172329 Phytochemical compositions including xanthones for anti-inflammatory, anti-cytokine storm, and other uses
07/05/2012US20120172323 Methods for treating malaria, tuberculosis and mac diseases
07/05/2012US20120172292 Method for protection of antimicrobial and anticancer drugs from inactivation by nitric oxide
07/05/2012US20120172291 Macrocyclic hepatitis c serine protease inhibitors
07/05/2012US20120172290 Anti-Viral Compounds
07/05/2012US20120172289 Multifunctional glycopeptide antibiotic derivatives for fluorescent imaging and photoactive antimicrobial therapy
07/05/2012US20120172288 Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions
07/05/2012US20120172287 Polypeptide Having Antibacterial Activity and Angiogenesis-Inducing Activity and Wound-Healing Drug Containing Said Polypeptide
07/05/2012US20120172286 Therapeutic use for alpha1 proteinase inhibitor in hematopoiesis
07/05/2012US20120172285 Methods and compositions for specific modulation of mcl-1
07/05/2012US20120171765 Factor VII or VIIa - Like Molecules
07/05/2012US20120171310 Plant essential oil-based antimicrobial fish filming compositions and methods of use
07/05/2012US20120171300 Durable Antimicrobial Composition Including a Surfactant
07/05/2012US20120171292 Luminescent porous silicon nanoparticles for targeted delivery and immunization
07/05/2012US20120171284 Celecoxib compositions
07/05/2012US20120171279 Strongly bound base-modified oligonucleotides
07/05/2012US20120171275 Local administration of gallium compositions to treat pain
07/05/2012US20120171256 Electrospun silk material systems for wound healing
07/05/2012US20120171252 Oil-in-water emulsion of mometasone and propylene glycol
07/05/2012US20120171249 Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
07/05/2012US20120171248 Compounds and methods for immunotherapy and diagnosis of tuberculosis
07/05/2012US20120171245 Inhibitors of influenza viruses replication
07/05/2012US20120171244 Mucosal boosting following parenteral priming
07/05/2012US20120171243 Method of preparing live viral vaccines by genetic engineering of viral genome
1 ... 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 ... 1798